Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>cas 2346620-55-9 99% Monabiravir N-1 Intermediate powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

cas 2346620-55-9 99% Monabiravir N-1 Intermediate powder

CAS NO.2346620-55-9

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Monabiravir N-1 Intermediate
  • Monabiravir N-1 Intermediate powder
  • 99% Monabiravir N-1 Intermediate

Quick Details

  • ProName: cas 2346620-55-9 99% Monabiravir N-1 ...
  • CasNo: 2346620-55-9
  • Molecular Formula: C16H23N3O7
  • Appearance: white
  • Application: Artemisia annua is used as antimalaria...
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

cas 2346620-55-9  99% Monabiravir N-1 Intermediate powder  

Product Name:    Monabiravir  N-1 Intermediate powder  

MF  : C16H23N3O7
Place of Origin  : China
Purity  : 99%
CAS : 2346620-55-9

 

Details

cas 2346620-55-9  99% Monabiravir N-1 Intermediate powder  

Product Name:    Monabiravir  N-1 Intermediate powder  

MF  : C16H23N3O7
Place of Origin  : China
Purity  : 99%
CAS : 2346620-55-9 

EIDD-2801 is the isopropylester prodrug of N4-hydroxycytidine. With improved oral bioavailability in non human primates, it is hydrolyzed in vivo, and distributes into tissues where it becomes the active 5'-triphosphate form. The active drug incorporates into the genome of RNA viruses, leading to an accumulation of mutations known as viral error catastrophe.